Overview
Hongbin Ji practices in Shanghai, China. Ji is rated as a Distinguished expert by MediFind in the treatment of Squamous Cell Lung Carcinoma. Their top areas of expertise are Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Lung Cancer, and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 191 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 11 articles in the study of Squamous Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung AdenocarcinomaJi isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerJi isDistinguished. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)
- Squamous Cell Lung Carcinoma
- Advanced
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Anal CancerJi isExperienced. Learn about Anal Cancer.
- Cervical CancerJi isExperienced. Learn about Cervical Cancer.
- EGFR Positive Lung Cancer
- Lung MetastasesJi isExperienced. Learn about Lung Metastases.
- MalnutritionJi isExperienced. Learn about Malnutrition.
- Muscle AtrophyJi isExperienced. Learn about Muscle Atrophy.